|
Omalizumab
|
D12.776.124.486.485.114.224.060.844 |
|
|
Hydrophthalmos
|
C16.131.384.480 |
|
|
Empowerment
|
F01.658.780.500 |
|
|
Power, Psychological
|
F01.658.780 |
|
|
Water Decolorization
|
N06.850.860.510.900.900.500 |
|
|
Buttermilk
|
J02.500.350.525.250 |
|
|
Charcot-Marie-Tooth Disease
|
C16.320.400.375.200 |
|
|
Raclopride
|
D02.455.426.559.389.127.250.937 |
|
|
Sulfamethoxypyridazine
|
D02.092.146.807.872 |
|
|
Sulfamonomethoxine
|
D02.092.146.807.877 |
|
|
Leukodystrophy, Metachromatic
|
C10.228.140.695.625.550 |
|
|
CD36 Antigens
|
D12.776.543.750.705.940.625.249 |
|
|
Corneal Dystrophy, Juvenile Epithelial of Meesmann
|
C16.320.290.162.204 |
|
|
Transfer RNA Aminoacylation
|
G02.111.012.055.860 |
|
|
CD52 Antigen
|
D12.776.395.550.448.190 |
|
|
Caspase 12
|
D12.644.360.075.405.550.920 |
|
|
Systematized Nomenclature of Medicine
|
L01.453.245.945.720 |
|
|
Arthritis, Psoriatic
|
C05.116.900.853.625.800.424 |
|
|
Hydronephrosis
|
C13.351.968.419.307 |
|
|
T-Cell Intracellular Antigen-1
|
D12.776.157.725.813.937 |
|
